CPIG
VOR icon

Chicago Partners Investment Group’s Vor Biopharma VOR Stock Holding History

Chicago Partners Investment Group’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-544
Closed -$22.8K – 1246
2025
Q2 		$22.8K Sell
544
-93
-15% -$822 ﹤0.01% 1089
2025
Q1 		$6.82K Buy
+637
New +$15.3K ﹤0.01% 932
2024
Q4 		– Sell
-680
Closed -$9.55K – 875
2024
Q3 		$9.55K Sell
680
-144
-17% -$2.63K ﹤0.01% 795
2024
Q2 		$15.2K Sell
824
-79
-9% -$2.56K ﹤0.01% 743
2024
Q1 		$33.9K Buy
903
+37
+4% +$1.62K ﹤0.01% 727
2023
Q4 		$40.5K Sell
866
-34
-4% -$1.4K ﹤0.01% 687
2023
Q3 		$37.4K Sell
900
-353
-28% -$19.1K ﹤0.01% 645
2023
Q2 		$74.7K Sell
1,253
-115
-8% -$10.5K ﹤0.01% 664
2023
Q1 		$126K Buy
1,368
+822
+151% +$91.1K 0.01% 638
2022
Q4 		$62.8K Sell
546
-181
-25% -$17.9K ﹤0.01% 624
2022
Q3 		$66K Buy
727
+82
+13% +$8.06K ﹤0.01% 572
2022
Q2 		$59K Buy
645
+2
+0.3% +$205 ﹤0.01% 579
2022
Q1 		$54K Sell
643
-91
-12% -$15.5K ﹤0.01% 551
2021
Q4 		$121K Sell
734
-209
-22% -$60.3K 0.01% 543
2021
Q3 		$316K Sell
943
-596
-39% -$177K 0.02% 427
2021
Q2 		$398K Buy
+1,539
New +$759K 0.03% 364

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACM
Ariose Capital Management Central, Hong Kong, Hong Kong $149M AUM 287.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Chicago Partners Investment Group's VOR Position: Q3 2025 in Review

Chicago Partners Investment Group sold out of Vor Biopharma (VOR) in Q3 2025, closing a stake of 544 shares — an estimated $22.8K sold.

Chicago Partners Investment Group first reported a position in VOR in Q2 2021 and held it in 16 quarters. The position peaked at $398K in Q2 2021. 37 funds tracked by Wall St. Rank hold VOR as of Q3 2025.

  • Chicago Partners Investment Group reported no remaining Vor Biopharma position as of Q3 2025 after selling out during the quarter.
  • Chicago Partners Investment Group sold 544 Vor Biopharma shares in Q3 2025, an estimated $22.8K.
  • Chicago Partners Investment Group first reported a position in Vor Biopharma in Q2 2021 and held it in 16 quarters.
  • Chicago Partners Investment Group's Vor Biopharma position peaked at $398K in Q2 2021.
  • 37 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2025.

Based on Chicago Partners Investment Group's 13F filing for Q3 2025, filed 30 Oct 2025.